| Peer-Reviewed

Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report

Received: 16 July 2020     Accepted: 18 August 2020     Published: 21 September 2020
Views:       Downloads:
Abstract

Sickle cell anaemia and Glucose-6-phosphate dehydrogenase deficiency have anaemia as major clinical consequence. The two disorders are rarely co-expressed in a patient. However, the pathological co-existence of both disorders tends to worsen and aggravate the clinical presentation in affected individuals. We report a diagnosis of the co-inheritance of these two disorders in a 43 year old man who was diagnosed with SCA at childhood. He was managed in a secondary health care facility since child hood. He has had multiple blood transfusions on account of repeated episodes of haemolytic anaemia which was solely attributed to SCA. He was referenced our center on account of recurrent severe heamolytic anaemia with a PCV of 9%. In the preceding 2 months to detecting his G6PD deficient status, he was having monthly blood transfusions on account of severe anaemia. Following the detection of his G6PD deficiency status and appropriate intervention with glutathione and selenium supplements and counseling to avoid exposure to oxidizing agents, he had a respite in the frequency of acute episodes of haemolysis necessitating blood transfusion, as well as an improvement in his steady state PCV of 16%. This case report underscores the importance of routine screening for G6PD status in patients with SCA so as to institute appropriate measures to reduce the worsening of incidence of acute episodes of haemolysis and the need for recurrent blood transfusions on account of this.

Published in International Journal of Genetics and Genomics (Volume 8, Issue 3)
DOI 10.11648/j.ijgg.20200803.12
Page(s) 102-105
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Glucose-6-phoshate Deficiency, Co-expression, Sickle Cell Disease, Pathological Co-existence

References
[1] Antwi-Baffour, S., Adjei, J. K., Forson, P. O., Akakpo, S. Kyeremeh, R. and Seidu, M. A. (2019). Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices Hindawi Anemia. 2019: 1-9 https://doi.org/10.1155/2019/3179173.
[2] L. van den Broek, E. Heylen, and M. van den Akker, “Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males,” Clinical Case Reports, vol. 4, no. 12, pp. 1135–1137, 2016. View at: Publisher Site | Google Scholar.
[3] Cappellini, M. D. and Fiorelli G. 2008. Glucose‐6‐phosphate dehydrogenase deficiency. Lancet 371: 64–74. [PubMed] [Google Scholar].
[4] Ronquist, G., and Theodorsson E.. 2007. Inherited, non‐spherocytic haemolysis due to deficiency of glucose‐6‐phosphate dehydrogenase. Scand. J. Clin. Lab. Invest. 67: 105–111. [PubMed] [Google Scholar].
[5] Manju T (2017) Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities. Genes Dis. 4 (4): 196–203.
[6] Prchal JT, Gregg XT. Red Cell Enzymes. Hematology/ASH Education Book. Available at http://asheducationbook.hematologylibrary.org/content/2005/1/19.full?sid=5fb34610-c164-4deb-9e85-0922086efaea. Accessed: June 29, 2020.
[7] Ogunkanbi, S. O, Adedoyin, O. T., Biliaminu, S. A. and Ernest S. K. (2019) Prevalence of Glucose-6- Phosphate Dehydrogenase Deficiency among Steady-State Sickle Cell Disease Children at University of Ilorin Teaching Hospital, Ilorin. Open Journal of Pediatrics, 9, 29-38.
[8] Umar M. Sickle cell anaemia: Prevention and control. 2010 http://www.gamji.com/article5000/NEW5314.HTM. Accessed July 28th 2020.
[9] Jidda M L, Ibrahim KK, Aiki G, Ngaski AA, Blessing J, et al. (2017) The Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Students of Sultan Abdurrahaman School of Health Technology Gwadabawa, Sokoto, North-Western Nigeria. International Blood Research & Reviews. 7 (4): 1-6.
[10] Firempong CK, Nsiah K, Yeboah FA. (2016). Some clinical and haematological effects of G6PD deficiency among individuals with sickle cell disorders in Kumasi, Ghana. The Journal of Medical Research. 2 (3): 81-85.
[11] Fasola, F. A., Fowodu, F. O., Shokunbi, W. A. and Kotila, T. R. (2019). The effect of the coinheritance of glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Niger Postgrad Med J; 26: 118-22.
[12] Kalliopi G, Ioannis GF, Dimitrios D, Konstantinos P, Panagiotis T, et al. (2019) Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review Oxidative medicine and cellular longevity 2019 (6): 1-7.
[13] Yang Y, Sauve A A. (2016) NAD (+) Metabolism: Bioenergetics, Signaling and Manipulation for Therapy. 1864 (12): 1787-1800.
[14] Belisario A R, Rodrigues S R, Elvin T N, Velloso R, Maria S C, et al. (2016) Glucose -6-Phosphate dehyrogenase Deficiency in Brazillian Children With Sickle Cell Anaemia is not Associated With Clinical Ischaemic Stroke or High-Risk Transcranial Doppler. Padiatr Blood Cancer. 63: 1046-1049.
[15] Benkerrou M., Alberti C., Couque N., Haouari Z., Ba A. et al. (2013). Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: A prospective study. Br J Haematol. 163: 646-54.
[16] Samuel Antwi-Baffour, Jonathan Kofi Adjei, Peter Owadee Forson, Stephen Akakpo, Ransford Kyeremeh and Mahmood Abdulai Seidu (2019). Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices. Hindawi Anemia. https://doi.org/10.1155/2019/317917.
Cite This Article
  • APA Style

    Patrick Olanrewaju Osho, Matilda Adesuwa Osagie Ojo, Evelyn Salewa Osho, Ndidi Aisha Okunnuga, Oluwatosin Idowu Oni, et al. (2020). Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report. International Journal of Genetics and Genomics, 8(3), 102-105. https://doi.org/10.11648/j.ijgg.20200803.12

    Copy | Download

    ACS Style

    Patrick Olanrewaju Osho; Matilda Adesuwa Osagie Ojo; Evelyn Salewa Osho; Ndidi Aisha Okunnuga; Oluwatosin Idowu Oni, et al. Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report. Int. J. Genet. Genomics 2020, 8(3), 102-105. doi: 10.11648/j.ijgg.20200803.12

    Copy | Download

    AMA Style

    Patrick Olanrewaju Osho, Matilda Adesuwa Osagie Ojo, Evelyn Salewa Osho, Ndidi Aisha Okunnuga, Oluwatosin Idowu Oni, et al. Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report. Int J Genet Genomics. 2020;8(3):102-105. doi: 10.11648/j.ijgg.20200803.12

    Copy | Download

  • @article{10.11648/j.ijgg.20200803.12,
      author = {Patrick Olanrewaju Osho and Matilda Adesuwa Osagie Ojo and Evelyn Salewa Osho and Ndidi Aisha Okunnuga and Oluwatosin Idowu Oni and Olugbenga Festus Fabusiwa},
      title = {Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report},
      journal = {International Journal of Genetics and Genomics},
      volume = {8},
      number = {3},
      pages = {102-105},
      doi = {10.11648/j.ijgg.20200803.12},
      url = {https://doi.org/10.11648/j.ijgg.20200803.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijgg.20200803.12},
      abstract = {Sickle cell anaemia and Glucose-6-phosphate dehydrogenase deficiency have anaemia as major clinical consequence. The two disorders are rarely co-expressed in a patient. However, the pathological co-existence of both disorders tends to worsen and aggravate the clinical presentation in affected individuals. We report a diagnosis of the co-inheritance of these two disorders in a 43 year old man who was diagnosed with SCA at childhood. He was managed in a secondary health care facility since child hood. He has had multiple blood transfusions on account of repeated episodes of haemolytic anaemia which was solely attributed to SCA. He was referenced our center on account of recurrent severe heamolytic anaemia with a PCV of 9%. In the preceding 2 months to detecting his G6PD deficient status, he was having monthly blood transfusions on account of severe anaemia. Following the detection of his G6PD deficiency status and appropriate intervention with glutathione and selenium supplements and counseling to avoid exposure to oxidizing agents, he had a respite in the frequency of acute episodes of haemolysis necessitating blood transfusion, as well as an improvement in his steady state PCV of 16%. This case report underscores the importance of routine screening for G6PD status in patients with SCA so as to institute appropriate measures to reduce the worsening of incidence of acute episodes of haemolysis and the need for recurrent blood transfusions on account of this.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report
    AU  - Patrick Olanrewaju Osho
    AU  - Matilda Adesuwa Osagie Ojo
    AU  - Evelyn Salewa Osho
    AU  - Ndidi Aisha Okunnuga
    AU  - Oluwatosin Idowu Oni
    AU  - Olugbenga Festus Fabusiwa
    Y1  - 2020/09/21
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ijgg.20200803.12
    DO  - 10.11648/j.ijgg.20200803.12
    T2  - International Journal of Genetics and Genomics
    JF  - International Journal of Genetics and Genomics
    JO  - International Journal of Genetics and Genomics
    SP  - 102
    EP  - 105
    PB  - Science Publishing Group
    SN  - 2376-7359
    UR  - https://doi.org/10.11648/j.ijgg.20200803.12
    AB  - Sickle cell anaemia and Glucose-6-phosphate dehydrogenase deficiency have anaemia as major clinical consequence. The two disorders are rarely co-expressed in a patient. However, the pathological co-existence of both disorders tends to worsen and aggravate the clinical presentation in affected individuals. We report a diagnosis of the co-inheritance of these two disorders in a 43 year old man who was diagnosed with SCA at childhood. He was managed in a secondary health care facility since child hood. He has had multiple blood transfusions on account of repeated episodes of haemolytic anaemia which was solely attributed to SCA. He was referenced our center on account of recurrent severe heamolytic anaemia with a PCV of 9%. In the preceding 2 months to detecting his G6PD deficient status, he was having monthly blood transfusions on account of severe anaemia. Following the detection of his G6PD deficiency status and appropriate intervention with glutathione and selenium supplements and counseling to avoid exposure to oxidizing agents, he had a respite in the frequency of acute episodes of haemolysis necessitating blood transfusion, as well as an improvement in his steady state PCV of 16%. This case report underscores the importance of routine screening for G6PD status in patients with SCA so as to institute appropriate measures to reduce the worsening of incidence of acute episodes of haemolysis and the need for recurrent blood transfusions on account of this.
    VL  - 8
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Haematology & Immunology, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria

  • Department of Haematology & Immunology, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria

  • Department of Radiology, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria

  • Oncology Unit, Department of Radiology, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria

  • Department of Haematology/Virology, University of Medical Sciences Teaching Hospital, Akure, Nigeria

  • Department of Medical Services, Ondo State primary Health Care Development Agency, Oke-Eda, Akure

  • Sections